Distinguished in Gingival Fibromatosis with Hypertrichosis

Vincenzo Leuzzi

Rome, IT 
Clinical Trials:Currently Recruiting for 1 Trial
Distinguished in Gingival Fibromatosis with Hypertrichosis
Rome, IT 
OverviewLocationsClinical Research

Overview

Vincenzo Leuzzi practices in Rome, Italy. Mr. Leuzzi is rated as a Distinguished expert by MediFind in the treatment of Gingival Fibromatosis with Hypertrichosis. His top areas of expertise are Phenylketonuria (PKU), Drug Induced Dyskinesia, Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, Movement Disorders, and Deep Brain Stimulation.

His clinical research consists of co-authoring 216 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Gingival Fibromatosis with Hypertrichosis.

Gender
Male

Locations

Rome, Italy
Other Locations
Sapienza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Enrollment Status: Recruiting
Publish Date: May 08, 2025
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: Autologous Erythrocytes, Dexamethasone Sodium Phosphate
Study Phase: Phase 3
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
View 2 Less Clinical Trial

216 Total Publications

Child Neurology: Ataxia Telangiectasia Presenting With Isolated Chorea and Cutaneous Lesions.
Child Neurology: Ataxia Telangiectasia Presenting With Isolated Chorea and Cutaneous Lesions.
Journal: Neurology
Published: September 11, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Leuzzi's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 25 Advanced Conditions
View All 55 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile